ZEB1 and prostate carcinoma: It had been well recognized that ZEB1 could inhibit the expression of miR200c in transcriptional level and miR200 could further suppressed the expression of BMI1, as an oncogene associated with adverse pathologic and clinical features in prostate cancer 45.